Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

In preclinical evaluations, Cardarine has been observed as a high-affinity, high-potency agonist at the PPARd receptor. The overview explains that activation of PPARd has been studied in connection ...

Uterine fibroids and endometriosis are two of the most common gynecologic diseases, affecting 15% to 80% of women of ...

International Olympic Committee confirmed on Wednesday that the Russian athlete committed irregularities and lost her medal, tennis player Markéta Vondroušová was banned for four years, and drug ...